• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过外源性SOX9利用联合驻留干细胞进行软骨再生以治疗骨关节炎

Exploiting Joint-Resident Stem Cells by Exogenous SOX9 for Cartilage Regeneration for Therapy of Osteoarthritis.

作者信息

Zhang Xiaowei, Wu Shili, Zhu Yong, Chu Cong-Qiu

机构信息

Division of Arthritis and Rheumatic Diseases, Oregon Health & Science University, Portland, OR, United States.

Section of Rheumatology, VA Portland Health Care System, Portland, OR, United States.

出版信息

Front Med (Lausanne). 2021 Feb 12;8:622609. doi: 10.3389/fmed.2021.622609. eCollection 2021.

DOI:10.3389/fmed.2021.622609
PMID:33681252
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7928416/
Abstract

The lack of effective treatment options for osteoarthritis (OA) is mostly due to the very limited regenerative capacity of articular cartilage. Mesenchymal stem cells (MSCs) have been most extensively explored for cell-based therapy to induce cartilage regeneration for OA. However, current expanded MSC-based approaches have significant drawbacks. On the other hand, osteoarthritic joints contain chondrocyte progenitors and MSCs in several niches which have the potential yet fail to differentiate into chondrocytes for cartilage regeneration. One of the underlying mechanisms of the failure is that these chondrocyte progenitors and MSCs in OA joints are deficient in the activity of chondrogenic transcription factor SOX9 (SRY-type high-mobility group box-9). Thereby, replenishing with exogenous SOX9 would reactivate the potential of these stem cells to differentiate into chondrocytes. Cell-permeable, super-positively charged SOX9 (scSOX9) protein is able to promote hyaline-like cartilage regeneration by inducing chondrogenic differentiation of bone marrow derived MSCs . This scSOX9 protein can be administered into osteoarthritic joints by intra-articular injection. This one-step, cell-free supplement of exogenous SOX9 may harness the regenerative potential of the intrinsic MSCs within the joint cavity to stimulate cartilage regeneration in OA.

摘要

骨关节炎(OA)缺乏有效的治疗方案,主要是因为关节软骨的再生能力非常有限。间充质干细胞(MSCs)已被广泛探索用于基于细胞的疗法,以诱导OA的软骨再生。然而,目前基于扩增MSCs的方法存在显著缺点。另一方面,骨关节炎关节在几个微环境中含有软骨细胞祖细胞和MSCs,它们有分化为软骨细胞以实现软骨再生的潜力,但却未能实现。这种失败的潜在机制之一是,OA关节中的这些软骨细胞祖细胞和MSCs缺乏软骨形成转录因子SOX9(SRY型高迁移率族盒9)的活性。因此,补充外源性SOX9将重新激活这些干细胞分化为软骨细胞的潜力。细胞可渗透的、带超强正电荷的SOX9(scSOX9)蛋白能够通过诱导骨髓来源的MSCs向软骨细胞分化来促进透明样软骨再生。这种scSOX9蛋白可以通过关节内注射施用于骨关节炎关节。这种一步式、无细胞补充外源性SOX9的方法可能利用关节腔内内在MSCs的再生潜力来刺激OA中的软骨再生。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b78b/7928416/c2f9f386d03c/fmed-08-622609-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b78b/7928416/c2f9f386d03c/fmed-08-622609-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b78b/7928416/c2f9f386d03c/fmed-08-622609-g0001.jpg

相似文献

1
Exploiting Joint-Resident Stem Cells by Exogenous SOX9 for Cartilage Regeneration for Therapy of Osteoarthritis.通过外源性SOX9利用联合驻留干细胞进行软骨再生以治疗骨关节炎
Front Med (Lausanne). 2021 Feb 12;8:622609. doi: 10.3389/fmed.2021.622609. eCollection 2021.
2
Regeneration of hyaline-like cartilage in situ with SOX9 stimulation of bone marrow-derived mesenchymal stem cells.通过SOX9刺激骨髓间充质干细胞原位再生透明样软骨。
PLoS One. 2017 Jun 30;12(6):e0180138. doi: 10.1371/journal.pone.0180138. eCollection 2017.
3
Efficiently directing differentiation and homing of mesenchymal stem cells to boost cartilage repair in osteoarthritis via a nanoparticle and peptide dual-engineering strategy.通过纳米颗粒和肽双重工程策略,高效指导间充质干细胞的分化和归巢,以促进骨关节炎中的软骨修复。
Biomaterials. 2025 Jan;312:122720. doi: 10.1016/j.biomaterials.2024.122720. Epub 2024 Jul 27.
4
Long-term durable repaired cartilage induced by SOX9 with bone marrow-derived mesenchymal stem cells.SOX9 联合骨髓间充质干细胞诱导的长期持久修复软骨。
Int J Med Sci. 2021 Jan 26;18(6):1399-1405. doi: 10.7150/ijms.52510. eCollection 2021.
5
Effect of in vitro chondrogenic differentiation of autologous mesenchymal stem cells on cartilage and subchondral cancellous bone repair in osteoarthritis of temporomandibular joint.自体间充质干细胞体外软骨分化对颞下颌关节骨关节炎软骨和软骨下松质骨修复的影响。
Int J Oral Maxillofac Surg. 2013 Feb;42(2):240-8. doi: 10.1016/j.ijom.2012.05.030. Epub 2012 Jul 2.
6
Coculture of equine mesenchymal stem cells and mature equine articular chondrocytes results in improved chondrogenic differentiation of the stem cells.马间充质干细胞与成熟马关节软骨细胞的共培养可改善干细胞的软骨形成分化。
Jpn J Vet Res. 2010 May;58(1):5-15.
7
Intra-articular injection of hUC-MSCs expressing miR-140-5p induces cartilage self-repairing in the rat osteoarthritis.关节内注射表达 miR-140-5p 的 hUC-MSCs 可诱导大鼠骨关节炎的软骨自我修复。
J Bone Miner Metab. 2020 May;38(3):277-288. doi: 10.1007/s00774-019-01055-3. Epub 2019 Nov 23.
8
Chaperonin 60 regulation of SOX9 ubiquitination mitigates the development of knee osteoarthritis.伴侣蛋白60对SOX9泛素化的调控减轻了膝骨关节炎的发展。
J Mol Med (Berl). 2016 Jul;94(7):755-69. doi: 10.1007/s00109-016-1422-3. Epub 2016 Apr 27.
9
Native joint-resident mesenchymal stem cells for cartilage repair in osteoarthritis.用于骨关节炎软骨修复的天然关节驻留间充质干细胞。
Nat Rev Rheumatol. 2017 Dec;13(12):719-730. doi: 10.1038/nrrheum.2017.182. Epub 2017 Nov 9.
10
Retroviral transduction with SOX9 enhances re-expression of the chondrocyte phenotype in passaged osteoarthritic human articular chondrocytes.用SOX9进行逆转录病毒转导可增强传代骨关节炎人关节软骨细胞中软骨细胞表型的重新表达。
Osteoarthritis Cartilage. 2005 Jan;13(1):80-9. doi: 10.1016/j.joca.2004.10.011.

引用本文的文献

1
Applications in osteochondral organoids for osteoarthritis research: from pathomimetic modeling to tissue engineering repair.骨软骨类器官在骨关节炎研究中的应用:从病理模拟建模到组织工程修复
Front Bioeng Biotechnol. 2025 Jul 23;13:1629608. doi: 10.3389/fbioe.2025.1629608. eCollection 2025.
2
The Expression Level of SOX Family Transcription Factors' mRNA as a Diagnostic Marker for Osteoarthritis.SOX家族转录因子mRNA表达水平作为骨关节炎的诊断标志物
J Clin Med. 2025 Feb 11;14(4):1176. doi: 10.3390/jcm14041176.
3
Therapeutic potential of SOX family transcription factors in osteoarthritis.

本文引用的文献

1
Long-term durable repaired cartilage induced by SOX9 with bone marrow-derived mesenchymal stem cells.SOX9 联合骨髓间充质干细胞诱导的长期持久修复软骨。
Int J Med Sci. 2021 Jan 26;18(6):1399-1405. doi: 10.7150/ijms.52510. eCollection 2021.
2
The local and circulating SOX9 as a potential biomarker for the diagnosis of primary bone cancer.局部和循环中的SOX9作为原发性骨癌诊断的潜在生物标志物。
J Bone Oncol. 2020 May 31;23:100300. doi: 10.1016/j.jbo.2020.100300. eCollection 2020 Aug.
3
Knee joint distraction in regular care for treatment of knee osteoarthritis: A comparison with clinical trial data.
SOX家族转录因子在骨关节炎中的治疗潜力
Ann Med. 2025 Dec;57(1):2457520. doi: 10.1080/07853890.2025.2457520. Epub 2025 Jan 31.
4
Deer antler reserve mesenchyme cells modified with miR-145 promote chondrogenesis in cartilage regeneration.经miR-145修饰的鹿茸储备间充质细胞促进软骨再生中的软骨形成。
Front Vet Sci. 2024 Dec 24;11:1500969. doi: 10.3389/fvets.2024.1500969. eCollection 2024.
5
Immunity-and-matrix-regulatory cells enhance cartilage regeneration for meniscus injuries: a phase I dose-escalation trial.免疫和基质调节细胞增强半月板损伤的软骨再生:I 期剂量递增试验。
Signal Transduct Target Ther. 2023 Nov 1;8(1):417. doi: 10.1038/s41392-023-01670-7.
6
Managing Temporomandibular Joint Osteoarthritis by Dental Stem Cell Secretome.通过牙髓干细胞 secretome 治疗颞下颌关节骨关节炎。
Stem Cell Rev Rep. 2023 Nov;19(8):2957-2979. doi: 10.1007/s12015-023-10628-9. Epub 2023 Sep 26.
7
Regeneration of articular cartilage defects: Therapeutic strategies and perspectives.关节软骨缺损的再生:治疗策略与展望。
J Tissue Eng. 2023 Mar 31;14:20417314231164765. doi: 10.1177/20417314231164765. eCollection 2023 Jan-Dec.
8
Sex-specific effects of calving season on joint health and biomarkers in Montana ranchers.蒙大拿州牧场主的产犊季节对关节健康和生物标志物的性别特异性影响。
BMC Musculoskelet Disord. 2023 Jan 31;24(1):80. doi: 10.1186/s12891-022-05979-2.
9
Production of Mesenchymal Progenitor Cell-Derived Extracellular Vesicles in Suspension Bioreactors for Use in Articular Cartilage Repair.悬浮生物反应器中骨髓间充质祖细胞衍生的细胞外囊泡的生产用于关节软骨修复。
Stem Cells Transl Med. 2022 Mar 3;11(1):73-87. doi: 10.1093/stcltm/szab008.
10
Cross-Communication Between Knee Osteoarthritis and Fibrosis: Molecular Pathways and Key Molecules.膝关节骨关节炎与纤维化之间的交叉通讯:分子途径与关键分子
Open Access J Sports Med. 2022 Mar 1;13:1-15. doi: 10.2147/OAJSM.S321139. eCollection 2022.
常规护理中膝关节牵伸治疗膝骨关节炎:与临床试验数据的比较。
PLoS One. 2020 Jan 22;15(1):e0227975. doi: 10.1371/journal.pone.0227975. eCollection 2020.
4
The role of joint distraction in the treatment of knee osteoarthritis: a systematic review and quantitative analysis.关节牵张在膝关节骨关节炎治疗中的作用:一项系统综述与定量分析
Orthop Res Rev. 2019 Aug 7;11:79-92. doi: 10.2147/ORR.S211060. eCollection 2019.
5
Correlation of SOX9 and NM23 genes with the incidence and prognosis of prostate cancer.SOX9和NM23基因与前列腺癌发病率及预后的相关性
Oncol Lett. 2019 Feb;17(2):2296-2302. doi: 10.3892/ol.2018.9828. Epub 2018 Dec 12.
6
Mesenchymal stem cell-based therapy of osteoarthritis: Current knowledge and future perspectives.基于间充质干细胞的骨关节炎治疗:当前知识和未来展望。
Biomed Pharmacother. 2019 Jan;109:2318-2326. doi: 10.1016/j.biopha.2018.11.099. Epub 2018 Nov 29.
7
Clinical results following intra-articular injection of adipose-derived stromal vascular fraction cells in patients with osteoarthritis of the knee.膝关节骨关节炎患者关节腔内注射脂肪源性基质血管成分细胞后的临床结果
Regen Ther. 2017 May 19;6:108-112. doi: 10.1016/j.reth.2017.04.002. eCollection 2017 Jun.
8
Green fluorescent proteins engineered for cartilage-targeted drug delivery: Insights for transport into highly charged avascular tissues.工程化绿色荧光蛋白用于软骨靶向药物递送:对进入高荷电无血管组织的运输的深入了解。
Biomaterials. 2018 Nov;183:218-233. doi: 10.1016/j.biomaterials.2018.08.050. Epub 2018 Aug 25.
9
Advances in stem cell therapy for cartilage regeneration in osteoarthritis.干细胞治疗在骨关节炎软骨再生中的研究进展。
Expert Opin Biol Ther. 2018 Aug;18(8):883-896. doi: 10.1080/14712598.2018.1502266. Epub 2018 Jul 26.
10
Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities.间质基质细胞:临床挑战与治疗机遇。
Cell Stem Cell. 2018 Jun 1;22(6):824-833. doi: 10.1016/j.stem.2018.05.004.